Guardicine

A Continuously Wearable Stroke Alarm – a new weapon against #1 cause of disability and #4 cause of mortality in our society

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Palo Alto, CA, USA
  • Currency USD

Company Summary

Guardicine solves a major gap in stroke treatment. For stroke patients, time is brain & life. Unfortunately, >90% of them are late for first line stroke medicine. The delay leads to high disability & mortality. The patients live in constant fear of another stroke due to high recurrence rate. Guardicine's proprietary device can automatically detect the start of a stroke and alert the patient to a hospital in time for critical early treatment.

Team

  • Mike Yang
    Founder

    Sr. Staff Engineer at Bell Labs, Intravascular Imaging, etc. A veteran in medical device industry. A key member for several diagnostic and surgical robotic equipment. A leader for multiple projects.

    MS EE, MS Bio, University of Kentucky, 1998
    BS Physics, Suzhou Univ

  • Chitra Venkatasubramanian
    Medical Officer

    MD, Clinical Associate Professor of Neurology and Neurological Sciences, Stanford University

    Fellowship: Stanford University Medical Center CA (2006)
    Residency: Coimbatore Medical College, India
    Board Certification: Vascular Neurology, American Board of Psychiatry and Neurology

  • Alex Gorelik
    Advisor

    Former GM at Informatica; Former founder, CTO and VP of Engineering at Exeros (acquired by IBM in 2009); Co-founder, CTO and VP of Engineering at Acta Technology (acquired by Business Objects in 2002 ).
    BS CS Columbia University; MS CS, Stanford University

  • Mike Yang

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free